Showing results (231-240 of 432) with videos related to

Sort By:
Pageof 44
Blood|September 6, 2019
Germline DDX41 mutations define a significant entity within adult MDS/AML patientsMarie Sébert, Marie Passet, Anna Raimbault, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2004
Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trialXavier Thomas, Jean-Michel Boiron, Françoise Huguet, et al.
British Journal of Haematology|May 11, 2012
Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFMShanti Natarajan-Amé, Sophie Park, Lionel Ades, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 studyCecile Pautas, Fatiha Merabet, Xavier Thomas, et al.
Journal of Hematology & Oncology|January 29, 2016
GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathwaysLaura Guerenne, Stéphanie Beurlet, Mohamed Said, et al.
Oncotarget|September 18, 2015
DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignanciesCarole Le Pogam, Satyananda Patel, Petra Gorombei, et al.
Haematologica|September 6, 2015
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasmsTariq I Mughal, Nicholas C P Cross, Eric Padron, et al.
Frontiers in Immunology|October 21, 2021
Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case SeriesGrégoire Martin de Frémont, Pierre Hirsch, Santiago Gimenez de Mestral, et al.
Ebiomedicine|May 6, 2018
Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating AgentsMatthieu Duchmann, Fevzi F Yalniz, Alessandro Sanna, et al.
Haematologica|December 18, 2009
Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des MyelodysplasiesCharikleia Kelaidi, Aspasia Stamatoullas, Odile Beyne-Rauzy, et al.
Pageof 44